Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.772 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.74045 | 63 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.74257 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.73814 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.90644 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.7747 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.75361 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.74491 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.74597 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.76162 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.72328 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.74935 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.94758 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.75296 | 63 |